Can-Fite BioPharma Ltd. (CANF)
AMEX: CANF
· Real-Time Price · USD
0.66
-0.01 (-1.79%)
At close: Aug 15, 2025, 3:59 PM
0.65
-1.62%
After-hours: Aug 15, 2025, 07:19 PM EDT
Can-Fite BioPharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 4.83M | 4.83M | 4.72M | 4.72M | 4.28M | 3.38M | 3.46M | 1.26M | 2.98M | 3.73M | 1.71M | 5.5M | 4.39M | 5.81M | 1.02M | 2.74M |
Short-Term Investments | 3.06M | 3.06M | 9K | 9K | 4.64M | 4.56M | 6.16M | 11.15M | 5.01M | 7.09M | 11.05M | 11.2M | 14.75M | 7.86M | 6.78M | 8.87M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | -105K | -123K | -110K | -126K | -141K | -157K | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 47K | n/a | n/a | n/a | 48K | 811K | 1.75M | 1.02M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -811K | -1.75M | -1.02M |
Other Current Assets | 1.09M | 77K | 1.1M | n/a | 78K | 1.12M | 1.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 8.98M | 8.98M | 5.83M | 5.83M | 9.91M | 9.06M | 10.91M | 13.38M | 9.16M | 12.56M | 14.59M | 17.67M | 20.07M | 14.47M | 9.55M | 12.63M |
Property-Plant & Equipment | 138K | 138K | 94K | 94K | 81K | 105K | 123K | 110K | 126K | 141K | 157K | 174K | 185K | 165K | 127K | 117K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 138K | 138K | 94K | 94K | 81K | 105K | 123K | 110K | 126K | 141K | 157K | 174K | 185K | 165K | 127K | 117K |
Total Assets | 9.12M | 9.12M | 5.92M | 5.92M | 9.99M | 9.17M | 11.03M | 13.49M | 9.28M | 12.71M | 14.75M | 17.85M | 20.25M | 14.64M | 9.68M | 12.74M |
Account Payables | 618K | 618K | 885K | 885K | 427K | 647K | 810K | 963K | 896K | 1.47M | 824K | 1.12M | 954K | 806K | 1M | 290K |
Deferred Revenue | 405K | n/a | 636K | n/a | 622K | 783K | 783K | 783K | 783K | 818K | 818K | 818K | 818K | 1M | 1M | 1M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 675K | 405K | n/a | 636K | 694K | n/a | n/a | n/a | 492K | n/a | n/a | n/a | 603K | n/a | n/a | n/a |
Total Current Liabilities | 2.05M | 2.05M | 1.99M | 1.99M | 2.02M | 2.21M | 2.23M | 2.89M | 2.5M | 2.8M | 2.15M | 2.9M | 2.73M | 2.15M | 2.36M | 2.06M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 1.58M | n/a | 1.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 1.63M | 1.63M | 1.46M | 1.46M | 1.73M | 1.72M | 1.93M | 2.1M | 2.31M | 2.48M | 2.7M | 2.92M | 3.14M | 3.15M | 3.37M | 3.6M |
Total Liabilities | 3.68M | 3.68M | 3.44M | 3.44M | 3.75M | 3.93M | 4.16M | 5M | 4.81M | 5.28M | 4.85M | 5.82M | 5.87M | 5.3M | 5.72M | 5.66M |
Total Debt | 104K | 104K | 57K | 57K | 40K | 51K | 66K | 48K | 62K | 74K | 87K | 109K | 124K | 102K | 68K | 55K |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 60.65M | 60.65M | 60.65M | 60.65M | 43.72M | 37.01M | 37.01M |
Retained Earnings | -166.36M | -166.36M | -162.44M | -162.44M | -158.48M | -156.83M | -155.07M | -153.4M | -150.85M | -147.83M | -145.3M | -143.11M | -140.67M | -133.97M | -130.57M | -127.35M |
Comprehensive Income | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M |
Shareholders Equity | 5.44M | 5.44M | 2.48M | 2.48M | 6.24M | 5.24M | 6.87M | 8.49M | 4.47M | 7.43M | 9.89M | 12.02M | 14.38M | 9.33M | 3.96M | 7.08M |
Total Investments | 3.06M | 3.06M | 9K | 9K | 4.64M | 4.56M | 6.16M | 11.15M | 5.01M | 7.09M | 11.05M | 11.2M | 14.75M | 7.86M | 6.78M | 8.87M |